相关实验视频

Updated: Jun 27, 2026

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

11.2K

在患有PTEN突变或PIK3CB突变的先进固体瘤的患者中,对AZD8186与多塞塔塞尔联合进行I期研究

A M Schram1, N Takebe2, A Chen2

  • 1Memorial Sloan Kettering Cancer Center, New York, USA; Weill Cornell Medical College, New York, USA.

ESMO open
|September 12, 2025
PubMed
概括

这一第一阶段试验结合了PI3K抑制剂AZD8186和在先进的固体瘤中进行多塞塔塞尔化疗. 这种组合显示出可控的毒性,其中中性质减退是主要问题,并观察到有限的临床活性.

关键词:
AZD8186 这是一本书.这就是PIK3CB.在这里,我们可以看到PTEN.篮球试验 篮球试验 篮球试验多塞塔克塞尔 (Docetaxel) 是一种药物.中性变质症 中性变质症 中性变质症固体瘤是一个固体瘤.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.8K

相关概念视频

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...